Acquisition Development Funding Westlake Village 
socalTECH
JULY 28, 2017
Westlake Village-based Sienna Biopharmaceuticals saw a healthy bump on its firs tday of trading as a public company, closing at $19.25 Sienna Biopharmaceuticals is venture backed by ARCH Venture Partners, Partner Fund, and Fidelity. Sienna Biopharmaceuticals is venture backed by ARCH Venture Partners, Partner Fund, and Fidelity.
socalTECH
JULY 5, 2017
Westlake Village-based Sienna Biopharmaceuticals , a startup biopharmaceuticals firm developing products for the medical dermatology and aesthetics market, has filed for an IPO. Sienna is venture backed by ARCH Venture Partners, Partner Fund, and Fidelity. Sienna said it is hoping to raised up to $74.8M READ MORE>>.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
socalTECH
JULY 27, 2017
Westlake Village-based Sienna Biopharmaceuticals had its IPO this morning on the NASDAQ, and was up over 33 percent in morning trading on its first day trading as SNNA, trading at around $19.98. The aesthetic medicine developer, led by President and CEO Dr. The aesthetic medicine developer, led by President and CEO Dr. Frederick C.
socalTECH
NOVEMBER 1, 2010
the developer of high speed switching chips which has major operations in Westlake Village, said late Friday that it has set its anticipated pricing range in its IPO. Inphi filed for an IPO in June, and is venture backed by Walden International, Tallwood, Mayfield Fund, and Samsung Electronics. Inphi Corp. , and $12.00
socalTECH
JUNE 17, 2010
a developer of high speed, analog semiconductors, has filed for an IPO, saying late Wednesday evening in a filing with the SEC it is looking to raise up to $115M in an IPO on the NYSE. Inphi is venture backed by Walden International, Tallwood, Mayfield Fund, and Samsung Electronics. In its S-1, the firm said it had net income of $7.3M
Expert insights. Personalized for you.
113 
Let's personalize your content